```html

Giant Cell Arteritis Symptoms: What to Know, How It’s Diagnosed, and When to Get Help

What is Giant cell arteritis symptoms?

Giant cell arteritis (GCA), also called temporal arteritis, is an inflammatory disease of the medium‑ and large‑size arteries, most often affecting the cranial branches of the carotid artery. The inflammation is driven by an abnormal immune response that leads to swelling of the arterial wall, narrowing or blockage of blood flow, and, if untreated, can cause permanent vision loss, stroke, or even death.

The term “giant cell” refers to the presence of unusually large, multinucleated immune cells that are seen under a microscope when a biopsy of an affected artery is examined. While the disease primarily targets the temporal arteries (those that run along the sides of the head), it can involve the ophthalmic artery, aorta, and other major vessels.

Most patients are over the age of 50, with a higher prevalence in women and people of Northern European descent. The exact trigger is unknown, but genetic and environmental factors are thought to play a role.

Common Causes

Giant cell arteritis is not caused by a single factor; rather, it results from a complex interaction between genetics, age‑related changes in the immune system, and possible environmental triggers. Below are the most widely recognized contributors and conditions that can mimic or precipitate GCA‑like symptoms.

• Age‑related immune dysregulation: The risk rises sharply after age 50.
• Genetic predisposition: HLA‑DRB1*04 alleles are strongly associated with GCA.
• Infections: Some studies suggest a link with viral infections (e.g., varicella‑zoster) that may trigger vascular inflammation.
• Polymyalgia rheumatica (PMR): Up to 50 % of patients with GCA also have PMR, a condition causing shoulder and hip stiffness.
• Smoking: Long‑term tobacco use appears to increase vascular inflammation risk.
• Other vasculitides: Conditions such as Takayasu arteritis or microscopic polyangiitis can present with overlapping symptoms.
• Autoimmune diseases: Rheumatoid arthritis, systemic lupus erythematosus, and Sjögren’s syndrome may coexist with GCA.
• Medications that alter immunity: Long‑term corticosteroid use can mask early symptoms, delaying diagnosis.
• Environmental factors: Geographic clustering suggests possible climate or seasonal influences.
• Physical trauma to the scalp or head: Rarely reported as a trigger for localized inflammation.

Associated Symptoms

The hallmark of GCA is headache, but the disease often presents with a constellation of systemic and local signs. Not every patient will have all of them, but the following are frequently reported:

• New‑onset, persistent headache – usually at the temples, described as throbbing or dull.
• Scalp tenderness – the skin over the affected artery may feel sore to the touch.
• Jaw claudication – pain or fatigue in the jaw while chewing.
• Vision changes – blurred vision, double vision, or sudden, painless loss of vision in one eye (ischemic optic neuropathy).
• Temporal artery abnormalities – the artery may feel thickened, hardened, or pulseless.
• Fever, chills, night sweats – low‑grade systemic fever is common.
• Unexplained weight loss – often 5–10 % of body weight over weeks.
• Fatigue and malaise – a generalized feeling of being unwell.
• Polymyalgia rheumatica symptoms – morning stiffness, aching in the shoulders, neck, and hips.
• Upper extremity claudication – arm pain or weakness when using the arms for prolonged periods (less common).

When to See a Doctor

Because GCA can cause irreversible vision loss within hours, prompt medical evaluation is essential. Seek care immediately if you experience any of the following:

• Sudden or worsening headache that is different from past headaches.
• Scalp tenderness or a palpable, tender artery on the side of the head.
• Jaw pain while chewing (jaw claudication).
• Any change in vision, especially loss of vision in one eye.
• Persistent fever, night sweats, or unexplained weight loss in someone over 50.
• New, unexplained muscle aches and stiffness in the shoulders or hips (possible polymyalgia rheumatica).
• Symptoms that do not improve with typical over‑the‑counter pain relievers.

Even if you are not sure, contacting a primary‑care physician or an urgent‑care clinic can prevent complications.

Diagnosis

Diagnosing GCA involves a combination of clinical assessment, blood tests, imaging, and sometimes a temporal artery biopsy. The goal is to confirm inflammation while ruling out other causes of headache and systemic symptoms.

1. Clinical Evaluation

• Detailed history (age, symptom onset, jaw claudication, visual changes).
• Physical exam focusing on temporal arteries, vision, and neurologic status.

2. Laboratory Tests

• Erythrocyte sedimentation rate (ESR) – usually markedly elevated (>50 mm/hr).
• C‑reactive protein (CRP) – another marker of inflammation, often >10 mg/L.
• Complete blood count – may show anemia of chronic disease.
• Liver function tests – can be mildly elevated.
• Autoimmune panel (ANA, ANCA) – usually negative, helping exclude other vasculitides.

3. Imaging

• Ultrasound of the temporal arteries – “halo sign” (dark, thickened vessel wall) is highly specific.
• Magnetic resonance angiography (MRA) or CT angiography – useful for assessing large‑vessel involvement (aorta, subclavian).
• Positron emission tomography (PET) – can detect inflammation in the aorta and branches, especially when symptoms are atypical.

4. Temporal Artery Biopsy

The gold‑standard test. A small segment of the temporal artery is removed and examined for:

• Granulomatous inflammation with multinucleated giant cells.
• Intimal hyperplasia and fragmentation of the internal elastic lamina.

Because the inflammation can be segmental, a negative biopsy does not completely rule out GCA, especially if clinical suspicion is high.

5. Diagnostic Criteria (American College of Rheumatology, 1990)

Three or more of the following establish a diagnosis:

• Age ≥ 50 years at disease onset.
• New‑type localized headache.
• Temporal artery abnormality (tenderness or decreased pulse).
• Elevated ESR ≥ 50 mm/h.
• Positive temporal artery biopsy.

Treatment Options

Rapid treatment is crucial to prevent permanent complications. The mainstay therapy is high‑dose corticosteroids, but newer agents allow steroid‑sparing strategies.

1. Immediate Medical Therapy

• High‑dose oral prednisone – 40–60 mg daily for most patients; 60 mg if visual symptoms are present.
• Intravenous methylprednisolone (1 g/day for 3 days) – reserved for patients with acute vision loss or severe ischemic symptoms.
• Start steroids **before** confirming the diagnosis if suspicion is high; taper slowly over months.

2. Steroid‑Sparing Agents

• Tocilizumab (IL‑6 receptor antagonist) – FDA‑approved for GCA; reduces relapse rates and allows lower steroid doses. Typical regimen: 162 mg subcutaneously weekly.
• Methotrexate – modest benefit; 10–25 mg weekly may be added for patients who cannot tolerate biologics.
• Azathioprine – occasional use in refractory cases.

3. Managing Side Effects

• Calcium & vitamin D supplementation + weight‑bearing exercise to prevent osteoporosis.
• Proton‑pump inhibitor if there is a history of peptic ulcer disease.
• Blood glucose monitoring for diabetics; consider endocrinology referral.
• Regular blood pressure checks; treat hypertension aggressively.

4. Home & Lifestyle Measures

• Maintain a balanced diet rich in calcium, vitamin D, and antioxidants.
• Gentle aerobic exercise (e.g., walking) as tolerated to preserve cardiovascular health.
• Avoid smoking and limit alcohol, both of which can exacerbate vascular inflammation.
• Use cool compresses for scalp tenderness; avoid tight headwear.

Prevention Tips

Because GCA is largely age‑related and has a strong genetic component, primary prevention is limited. However, certain strategies may lower overall vascular inflammation and improve outcomes:

• Control cardiovascular risk factors: Manage blood pressure, cholesterol, and diabetes.
• Stay physically active: Regular moderate exercise supports vascular health.
• Adopt an anti‑inflammatory diet: Emphasize fruits, vegetables, whole grains, fatty fish, and nuts; limit processed meats and sugary foods.
• Vaccinations: Keep flu and COVID‑19 vaccinations up to date, as infections can trigger inflammatory flares.
• Regular medical check‑ups: For patients with polymyalgia rheumatica or a family history of GCA, routine ESR/CRP monitoring can detect early inflammation.
• Avoid prolonged corticosteroid use without monitoring: If steroids are needed for other conditions, use the lowest effective dose and have periodic bone density scans.

Emergency Warning Signs

---

References: Mayo Clinic. “Giant Cell Arteritis.”; CDC. “Vasculitis Fact Sheet.”; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Temporal Arteritis.”; American College of Rheumatology 1990 Classification Criteria; European League Against Rheumatism (EULAR) recommendations for GCA management 2022; JAMA. 2023; “Tocilizumab in Giant Cell Arteritis.”

```